AASLD: New HCV Drug Speeds Viral Clearance (CME/CE)

BOSTON (MedPage Today) — Adding the investigational polymerase inhibitor ANA958 to standard care speeded up the clearance of hepatitis C, compared with standard care alone, a researcher reported here.

Post a Comment

Comments are closed.